Industry

NASHVILLE, Tenn.–(BUSINESS WIRE)–#ASCO22–Today, Sarah Cannon Research Institute announced that it will highlight its latest cancer research insights through more than 140 abstracts and presentations at the 2022 American Society of Clinical Oncology (ASCO®) Annual Meeting, taking place in Chicago and online from June 3-7, 2022. Experts from across Sarah Cannon Research Institute’s network will join … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Human Growth Hormone Treatment & Drugs Market 2022-2032” report has been added to ResearchAndMarkets.com’s offering. A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Bipolar Disorder Drugs and Treatment Market 2022-2032” report has been added to ResearchAndMarkets.com’s offering. A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical … [Read more…]

Recipients were chosen in part for their pledge to focus on research designed to advance cancer prevention and survival in minority populations, improve treatments PROVO, Utah & SEATTLE–(BUSINESS WIRE)–5 For The Fight, a nonprofit started by Qualtrics and fueled by thousands of private donors, announced today that seven new cancer researchers will get a boost … [Read more…]

Data describe rapid, safe and robust microbiome engraftment1 of MaaT033 in the gut of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome undergoing intensive chemotherapy and support the selection of a recommended dose for further development MaaT033 is an orally-administered high-richness, high-diversity, standardized, off-the-shelf, healthy-donors-derived Microbiome Ecosystem Therapy Company is on track with preparations … [Read more…]

Chief Psychiatric Medical Officer Dr. Yavar Moghimi honored as a Top Diversity Leader and Corporate Director Mairead McInerney honored as a Top Emerging Leader PHILADELPHIA–(BUSINESS WIRE)–#DEI—AmeriHealth Caritas, a national leader in Medicaid managed care and other solutions for those most in need, announced that two of its leaders were named to Modern Healthcare’s Top Diversity … [Read more…]

CAMBRIDGE, Mass. & TEL AVIV, Israel–(BUSINESS WIRE)–#AIpowered–Nucleai, a leader in Artificial Intelligence (AI) powered spatial analysis for pathology, and Ultivue, an industry leader in multiplexing tools for tissue biomarker studies, today announced a collaboration to advance the discovery of novel spatial biomarkers. The partnership will layer Nucleai’s cutting-edge AI spatial models on top of Ultivue’s … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User , By Region; Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global Lymphedema treatment market size is expected to reach USD 1,735.36 million by 2030 according to a new study. The … [Read more…]

SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News: Median Technologies (ALMDT) announced today that it will be presenting an abstract at the 2022 ASCO Annual Meeting, June 3-7, McCormick Place, Chicago, IL, USA (exhibition dates: June 4-6). Details of the session include: Abstract # / Poster # – The adjudication rates between readers in Blinded Independent Central Review … [Read more…]

VIENNA–(BUSINESS WIRE)–Proxygen, a leader in the discovery and development of molecular glue degraders, announced today that the company has entered into a strategic multi-year research collaboration and license agreement with Merck. Proxygen is eligible to receive up to €495 million ($554 million at the average USD/EUR FX rate of Q1 2022) in continuous R&D funding, … [Read more…]